How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".

Antiretroviral preexposure prophylaxis (PrEP; emtricitabine and tenofovir disoproxil fumarate [Truvada]) prevents HIV without penalizing sexual pleasure, and may even enhance pleasure (e.g., by reducing HIV-related anxiety). However, concern about sexual risk behavior increasing with PrEP use (risk compensation) and corresponding stereotypes of promiscuity may undermine PrEP's preventive potential. In this commentary, we review literature on sexual behavior change accompanying PrEP use, discuss risk compensation concerns and the "Truvada whore" stereotype as PrEP barriers, question the appropriateness of restricting PrEP access because of risk compensation, and consider sexual pleasure as a benefit of PrEP, an acceptable motive for seeking PrEP, and a core element of health. It is essential for science to trump stereotypes and sex-negative messaging in guiding decision-making affecting PrEP access and uptake.

[1]  J. Fortenberry.  The evolving sexual health paradigm: transforming definitions into sexual health practices , 2013, AIDS.

[2]  I. Stolte,et al.  What do Dutch MSM think of preexposure prophylaxis to prevent HIV-infection? A cross-sectional study , 2015, AIDS.

[3]  S. Kalichman,et al.  Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies , 2007, Current HIV/AIDS reports.

[4]  John T Brooks,et al.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.

[5]  Brian Mustanski,et al.  Intimacy, Monogamy, and Condom Problems Drive Unprotected Sex Among Young Men in Serious Relationships with Other Men: A Mixed Methods Dyadic Study , 2013, Archives of Sexual Behavior.

[6]  J. D. de Wit,et al.  Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men , 2012, Sexually Transmitted Infections.

[7]  K. Kubicek,et al.  Attitudes and Perceptions of Biomedical HIV Prevention Methods: Voices from Young Men Who Have Sex with Men , 2015, Archives of Sexual Behavior.

[8]  S. Cu-Uvin,et al.  Antiretrovirals and safer conception for HIV-serodiscordant couples , 2012, Current opinion in HIV and AIDS.

[9]  J. Auerbach,et al.  Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. , 2015, AIDS patient care and STDs.

[10]  W. Cunningham,et al.  Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. , 2011 .

[11]  X. Zhong,et al.  Pre-Exposure Prophylaxis for the Prevention of HIV Infection in High Risk Populations: A Meta-Analysis of Randomized Controlled Trials , 2014, PloS one.

[12]  L. Grohskopf,et al.  Sexual Risk Behavior Among HIV-Uninfected Men Who Have Sex With Men Participating in a Tenofovir Preexposure Prophylaxis Randomized Trial in the United States , 2013, Journal of acquired immune deficiency syndromes.

[13]  M. Mimiaga,et al.  Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. , 2012, AIDS patient care and STDs.

[14]  Sung-Jae Lee,et al.  Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. , 2012, AIDS patient care and STDs.

[15]  M. Dybul,et al.  Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study , 2012, BMJ Open.

[16]  David M. Tellalian,et al.  Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. , 2013, AIDS patient care and STDs.

[17]  P. Polgreen,et al.  Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Julia Belluz.  The Truvada wars , 2014, BMJ : British Medical Journal.

[19]  J. Walsh,et al.  Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa? , 2013, Sexually Transmitted Infections.

[20]  J. Lama,et al.  Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru. , 2014, AIDS research and human retroviruses.

[21]  Pai-Lien Chen,et al.  Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial , 2008, Sexually transmitted diseases.

[22]  Katrien Fransen,et al.  Preexposure prophylaxis for HIV infection among African women. , 2012, The New England journal of medicine.

[23]  Sung-Jae Lee,et al.  Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships , 2011, AIDS care.

[24]  J. Justman,et al.  Adherence and Acceptability in MTN 001: A Randomized Cross-Over Trial of Daily Oral and Topical Tenofovir for HIV Prevention in Women , 2013, AIDS and Behavior.

[25]  C. Hoff,et al.  Attitudes Towards PrEP and Anticipated Condom Use Among Concordant HIV-Negative and HIV-Discordant Male Couples. , 2015, AIDS patient care and STDs.

[26]  J. Baeten,et al.  HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention , 2014, Journal of acquired immune deficiency syndromes.

[27]  K. Gamarel,et al.  Intimacy Motivations and Pre-exposure Prophylaxis (PrEP) Adoption Intentions Among HIV-Negative Men Who Have Sex with Men (MSM) in Romantic Relationships , 2015, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[28]  A. van der Straten,et al.  American Journal of Epidemiology Practice of Epidemiology Biomarker Validation of Reports of Recent Sexual Activity: Results of a Randomized Controlled Study in Zimbabwe , 2022 .

[29]  M. Hogben,et al.  Disinhibition and risk compensation: scope, definitions, and perspective. , 2008, Sexually transmitted diseases.

[30]  C. Kuo.  PrEP Acceptability, Access and Predicted User Behaviors in US Male Sex Workers: Implications for Effectiveness , 2014 .

[31]  S. Hosek,et al.  The Acceptability and Feasibility of an HIV Preexposure Prophylaxis (PrEP) Trial With Young Men Who Have Sex With Men , 2013, Journal of acquired immune deficiency syndromes.

[32]  K. Underhill.  Risk-Taking and Rulemaking: Addressing Risk Compensation Behavior Through FDA Regulation of Prescription Drugs , 2013 .

[33]  Kimberly A. Koester,et al.  Client and Provider Perspectives on New HIV Prevention Tools for MSM in the Americas , 2015, PloS one.

[34]  G. Garnett,et al.  Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness , 2008, AIDS.

[35]  J. Dovidio,et al.  The Impact of Patient Race on Clinical Decisions Related to Prescribing HIV Pre-Exposure Prophylaxis (PrEP): Assumptions About Sexual Risk Compensation and Implications for Access , 2014, AIDS and Behavior.

[36]  S. Sanders,et al.  Condom use errors and problems: a global view. , 2012, Sexual health.

[37]  K. Amico,et al.  Helping our patients take HIV pre‐exposure prophylaxis (PrEP): a systematic review of adherence interventions , 2014, HIV medicine.

[38]  K. Mayer,et al.  HIV Providers’ Perceived Barriers and Facilitators to Implementing Pre-exposure Prophylaxis in Care Settings: A Qualitative Study , 2014, AIDS and Behavior.

[39]  R. Haubrich,et al.  Will risk compensation accompany pre-exposure prophylaxis for HIV? , 2014, The virtual mentor : VM.

[40]  J. Stockman,et al.  Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men , 2012 .

[41]  Megha L Mehrotra,et al.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. , 2014, The Lancet. Infectious diseases.

[42]  S. Buchbinder,et al.  Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco , 2014, PLoS medicine.

[43]  P. Halkitis,et al.  Acceptability of PrEP Uptake Among Racially/Ethnically Diverse Young Men Who Have Sex With Men: The P18 Study. , 2015, AIDS education and prevention : official publication of the International Society for AIDS Education.

[44]  D. Glidden,et al.  No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis , 2013, PloS one.

[45]  G. Ippolito,et al.  Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists , 2013, BMC Infectious Diseases.

[46]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[47]  W. Duffus,et al.  Preexposure Prophylaxis for HIV Infection: Healthcare Providers’ Knowledge, Perception, and Willingness to Adopt Future Implementation in the Southern US , 2012, Southern medical journal.

[48]  G. Guest,et al.  Preparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEP , 2015, PloS one.

[49]  K. Underhill.  Study designs for identifying risk compensation behavior among users of biomedical HIV prevention technologies: balancing methodological rigor and research ethics. , 2013, Social science & medicine.

[50]  M. Carrieri,et al.  Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France , 2012, AIDS care.

[51]  J. Baeten.  Pre-exposure prophylaxis (PrEP) for HIV prevention , 2012 .

[52]  S. Sanders,et al.  Condom Discomfort and Associated Problems With Their Use Among University Students , 2005, Journal of American college health : J of ACH.

[53]  K. Underhill.  Intimacy, Condom Use, and Pre-Exposure Prophylaxis (PrEP) Acceptability among Men Who Have Sex with Men (MSM) in Primary Partnerships: a Comment on Gamarel and Golub , 2015, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[54]  R. Rothenberg,et al.  Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). , 2012, AIDS education and prevention : official publication of the International Society for AIDS Education.

[55]  B. Raymond,et al.  Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance. , 2013, American journal of preventive medicine.

[56]  J. Haukoos,et al.  Knowledge of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men in Denver, Colorado , 2014, AIDS and Behavior.

[57]  Peter L. Anderson,et al.  Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men , 2012, Science Translational Medicine.

[58]  P. Sullivan,et al.  Racial Differences in the Accuracy of Perceived Partner HIV Status among Men who have Sex with Men (MSM) in Atlanta, Georgia , 2015, Journal of the International Association of Providers of AIDS Care.

[59]  D. Operario,et al.  Pre-exposure Prophylaxis State of the Science: Empirical Analogies for Research and Implementation , 2010, Current HIV/AIDS reports.

[60]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[61]  R. Haubrich,et al.  Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP , 2015, AIDS and Behavior.

[62]  J. Wilton,et al.  Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations. , 2013, AIDS research and human retroviruses.

[63]  J. Baeten,et al.  Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. , 2013, The Lancet. Infectious diseases.

[64]  J Hedlund,et al.  Risky business: safety regulations, risk compensation, and individual behavior , 2000, Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention.

[65]  T. Neilands,et al.  Ambiguity, Ambivalence, and Apprehensions of Taking HIV-1 Pre-Exposure Prophylaxis among Male Couples in San Francisco: A Mixed Methods Study , 2012, PloS one.

[66]  Kimberly A. Koester,et al.  Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes , 2016, AIDS and Behavior.

[67]  Charlene A Flash,et al.  Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis. , 2014, AIDS patient care and STDs.

[68]  D. Tolman,et al.  Gender matters: Constructing a model of adolescent sexual health , 2003, Journal of sex research.

[69]  J. Aberg,et al.  Self-Perception of HIV Risk and Candidacy for Pre-Exposure Prophylaxis Among Men Who Have Sex with Men Testing for HIV at Commercial Sex Venues in New York City. , 2014, LGBT health.

[70]  William J. Kowalczyk,et al.  Preexposure Prophylaxis and Predicted Condom Use Among High-Risk Men Who Have Sex With Men , 2010, Journal of acquired immune deficiency syndromes.

[71]  J. Parsons,et al.  Willingness to Take PrEP and Potential for Risk Compensation Among Highly Sexually Active Gay and Bisexual Men , 2015, AIDS and Behavior.

[72]  J. Herbst,et al.  Estimating HIV Protective Effects of Method Adherence With Combinations of Preexposure Prophylaxis and Condom Use Among African American Men Who Have Sex With Men , 2015, Sexually transmitted diseases.

[73]  A. Carballo-Diéguez,et al.  Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback , 2008, AIDS care.